These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37345161)

  • 21. Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer.
    Hyun KA; Koo GB; Han H; Sohn J; Choi W; Kim SI; Jung HI; Kim YS
    Oncotarget; 2016 Apr; 7(17):24677-87. PubMed ID: 27013581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Immune-Magnetophoretic Device for the Selective and Precise Enrichment of Circulating Tumor Cells from Whole Blood.
    Chelakkot C; Ryu J; Kim MY; Kim JS; Kim D; Hwang J; Park SH; Ko SB; Park JW; Jung MY; Kim RN; Song K; Kim YJ; Choi YL; Lee HS; Shin YK
    Micromachines (Basel); 2020 May; 11(6):. PubMed ID: 32486306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enumeration and Molecular Characterization of Circulating Tumor Cell Using an Epithelial Cell Adhesion Molecule/Vimentin/Epidermal Growth Factor Receptor Joint Capture System in Lung Cancer.
    Jiang W; Wu J; Lin X; Chen Z; Lin L; Yang J
    Clin Med Insights Oncol; 2024; 18():11795549241231568. PubMed ID: 38525298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analogous detection of circulating tumor cells using the AccuCyte
    van der Toom EE; Groot VP; Glavaris SA; Gemenetzis G; Chalfin HJ; Wood LD; Wolfgang CL; de la Rosette JJMCH; de Reijke TM; Pienta KJ
    Prostate; 2018 Mar; 78(4):300-307. PubMed ID: 29285777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations between the Epithelial-Mesenchymal Transition Phenotypes of Circulating Tumor Cells and the Clinicopathological Features of Patients with Colorectal Cancer.
    Wu F; Zhu J; Mao Y; Li X; Hu B; Zhang D
    Dis Markers; 2017; 2017():9474532. PubMed ID: 29430076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients.
    Togo S; Katagiri N; Namba Y; Tulafu M; Nagahama K; Kadoya K; Takamochi K; Oh S; Suzuki K; Sakurai F; Mizuguchi H; Urata Y; Takahashi K
    Oncotarget; 2017 May; 8(21):34884-34895. PubMed ID: 28432274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The construction of EpCAM/vimentin-PLGA/lipid immunomagnetic microspheres and the isolation of circulating tumor cells from lung cancer.
    Li G; Wang Y; Tan G
    Int J Clin Exp Pathol; 2018; 11(12):5561-5570. PubMed ID: 31949643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Greatly Enhanced CTC Culture Enabled by Capturing CTC Heterogeneity Using a PEGylated PDMS-Titanium-Gold Electromicrofluidic Device with Glutathione-Controlled Gentle Cell Release.
    Kwizera EA; Ou W; Lee S; Stewart S; Shamul JG; Xu J; Tait N; Tkaczuk KHR; He X
    ACS Nano; 2022 Jul; 16(7):11374-11391. PubMed ID: 35797466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Membrane Hsp70-A Novel Target for the Isolation of Circulating Tumor Cells After Epithelial-to-Mesenchymal Transition.
    Breuninger S; Stangl S; Werner C; Sievert W; Lobinger D; Foulds GA; Wagner S; Pickhard A; Piontek G; Kokowski K; Pockley AG; Multhoff G
    Front Oncol; 2018; 8():497. PubMed ID: 30443493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel.
    Blassl C; Kuhlmann JD; Webers A; Wimberger P; Fehm T; Neubauer H
    Mol Oncol; 2016 Aug; 10(7):1030-42. PubMed ID: 27157930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating Tumor Cells: A Review of Non-EpCAM-Based Approaches for Cell Enrichment and Isolation.
    Gabriel MT; Calleja LR; Chalopin A; Ory B; Heymann D
    Clin Chem; 2016 Apr; 62(4):571-81. PubMed ID: 26896446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ALCAM: A Novel Surface Marker on EpCAM
    Signorelli R; Giret TM; Umland O; Hadisurya M; Lavania S; Charles Richard JL; Middleton A; Boone MM; Ergonul AB; Tao WA; Amirian H; Iliuk A; Khan A; Diaz R; Cortes DB; Garcia-Buitrago M; Charles Jacob HK
    Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009530
    [No Abstract]   [Full Text] [Related]  

  • 33. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
    Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
    Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi-Marker Immunofluorescent Staining and PD-L1 Detection on Circulating Tumour Cells from Ovarian Cancer Patients.
    Asante DB; Morici M; Mohan GRKA; Acheampong E; Spencer I; Lin W; van Miert P; Gibson S; Beasley AB; Ziman M; Calapre L; Meniawy TM; Gray ES
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating tumor cell microseparator based on lateral magnetophoresis and immunomagnetic nanobeads.
    Kim S; Han SI; Park MJ; Jeon CW; Joo YD; Choi IH; Han KH
    Anal Chem; 2013 Mar; 85(5):2779-86. PubMed ID: 23384087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers.
    Armstrong AJ; Marengo MS; Oltean S; Kemeny G; Bitting RL; Turnbull JD; Herold CI; Marcom PK; George DJ; Garcia-Blanco MA
    Mol Cancer Res; 2011 Aug; 9(8):997-1007. PubMed ID: 21665936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-Efficiency Isolation and Rapid Identification of Heterogeneous Circulating Tumor Cells (CTCs) Using Dual-Antibody-Modified Fluorescent-Magnetic Nanoparticles.
    Wang Z; Sun N; Liu H; Chen C; Ding P; Yue X; Zou H; Xing C; Pei R
    ACS Appl Mater Interfaces; 2019 Oct; 11(43):39586-39593. PubMed ID: 31577122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating tumor cell enumeration for improved screening and disease detection of patients with colorectal cancer.
    Tsai WS; Hung WS; Wang TM; Liu H; Yang CY; Wu SM; Hsu HL; Hsiao YC; Tsai HJ; Tseng CP
    Biomed J; 2021 Dec; 44(6 Suppl 2):S190-S200. PubMed ID: 35292267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy.
    Onstenk W; Kraan J; Mostert B; Timmermans MM; Charehbili A; Smit VT; Kroep JR; Nortier JW; van de Ven S; Heijns JB; Kessels LW; van Laarhoven HW; Bos MM; van de Velde CJ; Gratama JW; Sieuwerts AM; Martens JW; Foekens JA; Sleijfer S
    Mol Cancer Ther; 2015 Mar; 14(3):821-7. PubMed ID: 25552367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective isolation of magnetic nanoparticle-mediated heterogeneity subpopulation of circulating tumor cells using magnetic gradient based microfluidic system.
    Kwak B; Lee J; Lee D; Lee K; Kwon O; Kang S; Kim Y
    Biosens Bioelectron; 2017 Feb; 88():153-158. PubMed ID: 27503409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.